2003-December Archives by Date

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...

Starting: Mon Dec 1 08:07:01 2003
Ending: Mon Dec 29 11:39:00 2003
Messages: 99

• [Ip-health] MSF press release: WHO supports use of twice-a-day pill for AIDS   Sean.HEALY@geneva.msf.org
• [Ip-health] Click to demand AIDS Action from ALL the US Presidential Candidates!   Paul Davis
• [Ip-health] ABC on "Open Access Biotechnologyl   James Love
• [Ip-health] Kucinich statement for World AIDS Day   Mike Palmedo
• [Ip-health] Wash Post op-ed: Prescription for Reform   Mike Palmedo
• [Ip-health] NEW: 5th edition of Untangling the web of Price Reductions   Sean.HEALY@geneva.msf.org
• [Ip-health] Roger Bates' WAD column   Mike Palmedo
• [Ip-health] "Ask the Experts" about Drug Reimportation   James Love
• [Ip-health] Medicare: not yet law, but already change is in the air   James Love
• [Ip-health] Reuters: Cuba develops new Flu type B vaccine   Suerie MOON
• [Ip-health] PBS and US Aust Free Trade update   Mr Buddhima Lokuge
• [Ip-health] US Patent Policy, Biotech, and African Agriculture: The Case for Policy Change   Mike Palmedo
• [Ip-health] Oxfam: Robbing the Poor to Pay the Rich? How the US Keeps Medicines from the World's Poorest   Mike Palmedo
• [Ip-health] "Launching Pharmaceutical Megabrands: Best Practices in Marketing Blockbusters"   Mike Palmedo
• [Ip-health] Lancet: USA-Morocco deal may extend drug patents to 30 years   Nathan Ford
• [Ip-health] The Economist - Why Big Pharma Needs a New Business Model   Mike Palmedo
• [Ip-health] Fwd: [Aushealthecon] Australia Institute discussion paper on PBS   james@medibank.com.au
• [Ip-health] Stealth Merger: Drug Companies and Government Medical Research: Some of the National Institutes of Health's top scientists are also collecting paychecks and stock options from biomedical firms.   James Love
• [Ip-health] Crossing borders to fight HIV/AIDS   Kirsten Myhr
• [Ip-health] Global Business Coalition teams up w/ Global Fund   Kate Krauss
• [Ip-health] Glaxo chief: Our drugs do not work on most patients   Alan Story
• [Ip-health] Question about patents on pipeline HPV vaccine   Mike Palmedo
• [Ip-health] Pharma ghost writers   Sean Flynn
• [Ip-health] News: HIV/AIDS Activists Protest Central America Trade Talks   Kate Krauss
• [Ip-health] Breakthrough in SA AIDS patent case   Sean Flynn
• [Ip-health] NYT-In Ethiopia's Malaria War, Weapons Are the Issue   Rachel COHEN
• [Ip-health] TODAY AT NOON: ACTIVISTS ZAPPED CAFTA NEGOTIATIONS IN DC   Kate Krauss
• [Ip-health] CMAJ Editorial: Patently necessary: improving global access to essential medicines / Éditorial: Pour un meilleur accès aux médicaments essentiels , partout dans le monde   Richard Elliott
• [Ip-health] Op-ed: Le Canada sabotera-t-il son initiative pour l'accès aux médicaments?   Richard Elliott
• [Ip-health] SA GSK settlement announced   sean.flynn@cptech.org
• [Ip-health] TAC statement on SA settlement   Sean Flynn
• [Ip-health] Pension fund plans letter to Glaxo on AIDS drugs   Mike Palmedo
• [Ip-health] AIDS Healthcare Foundation Says SA Competition Commission Settlement on GSK's' AIDS Drug Pricing "Too Little, Too Late"   Mike Palmedo
• [Ip-health] Interpress Service: U.S.-Central America Deal Could Block Cheap AIDS Drugs   Mike Palmedo
• [Ip-health] S.A. Competition Commission Case   B.Baker@neu.edu
• [Ip-health] Press clips on SA Settlement   Sean Flynn
• [Ip-health] Indian cos stand a good chance of winning against Novartis: Natco   Joana Ramos
• [Ip-health] picking one's competitors   James Love
• [Ip-health] picking one's competitors   Zackie Achmat
• [Ip-health] Indian Patent Act to Be Amended   Mike Palmedo
• [Ip-health] Chimp genome placed in public domain   Mike Palmedo
• [Ip-health] Zogby poll on trade   Kate Krauss
• [Ip-health] Resources for the Future: American Patent Policy, Biotechnology, and African Agriculture - The Case for Policy Change   Mike Palmedo
• [Ip-health] Theresa Agovino: US may overwhelm Canadian Pharmacies   Joy Spencer
• [Ip-health] MSF Press Release: US Pressure Threatening Access to Medicines in Central America   Rachel COHEN
• [Ip-health] US state(s) threatening Pharma on anti-competitive or public health grounds - what language to hit home?   kscott
• [Ip-health] Generic imatinib mesylate ( glivec) in India   Joana Ramos
• [Ip-health] US state(s) threatening Pharma on anti-competitive or public health grounds - what language to hit home?   George M. Carter
• [Ip-health] Papers from December 4, Columbia R&D workshop   James Love
• [Ip-health] WHO discussions on fixed dose combinations   James Love
• [Ip-health] Guardian Unlimited The Guardian UK drug firms accused of failing NHS   Alan Story
• [Ip-health] Australia: Drug firms fund disease awareness   Robert Weissman
• [Ip-health] Revised Essential Medicines Game Theory Paper   David Opderbeck
• [Ip-health] op-ed in Vancouver Sun re Canadian patent law amendment   Richard Elliott
• [Ip-health] Waxman, Rangel and Levin letter to Zoellick on CAFTA   Mike Palmedo
• [Ip-health] Reuters on stalling WTO negotiations   Mike Palmedo
• [Ip-health] Religious Investors Tell Pfizer: Honor the Agreement to Get AIDS Drug Rescriptor to Poor   Mike Palmedo
• [Ip-health] Natco Pharma launches 2 new anti-cancer drugs   Joana Ramos
• [Ip-health] FW: David Takes ON Goliath   John R. Fulton
• [Ip-health] New Medicines Seldom Contain Anything New, Study Finds   James Love
• [Ip-health] Report to Recipient(s)   SUMGAT01/Oxfam%OXFAM@oxfam.org.uk
• [Ip-health] Report to Recipient(s)   SUMGAT01/Oxfam%OXFAM@oxfam.org.uk
• [Ip-health] Reuters: Central American Nations Reach Trade Deal   Mike Palmedo
• [Ip-health] CalPERS & Glaxo   Kate Krauss
• [Ip-health] Sick people lose out in U.S.-Central American trade deal finalized today   Sharonann Lynch
• [Ip-health] USTR on the CAFTA deal   Mike Palmedo
• [Ip-health] Kings Fund attacks pharma on R&D priorities   James Love
• [Ip-health] NYT-A Pact on Central America Trade Zone, Minus One   Rachel COHEN
• [Ip-health] WP-Accord Reached on Free Trade; Hill Fight Pssible Over US Pact with Central Americans   Rachel COHEN
• [Ip-health] Indian Patent Act to Be Amended   michael.davis@law.csuohio.edu
• [Ip-health] EU's DG Trade 2004 Work Program   Robert Weissman
• [Ip-health] U.S. 's Misguided and Bad-Faith Attack on the WHO's 3-by-5 Plan   B.Baker@neu.edu
• [Ip-health] How the drug industry is branding itself with bioethics   Robert Weissman
• [Ip-health] FT: Cafta deal may hang on single vote in Congress   Rene Shen
• [Ip-health] Re: [ATAC-Discuss] Docs call for Abbott boycott - part 1   George M. Carter
• [Ip-health] More on Price Controls   George M. Carter
• [Ip-health] A bunch of business groups' statements on CAFTA   Mike Palmedo
• [Ip-health] The Australian: US attempt to wind back generic drugs   Mike Palmedo
• [Ip-health] WSJ: Abbott Lifts Price of Norvir 400%   Mike Palmedo
• [Ip-health] FTC press release on antitrust ruling against 3 drug firms   Mike Palmedo
• [Ip-health] Letter from Rep. Allen to Robert Zoellick on US-Australia FTA negotiations   Mike Palmedo
• [Ip-health] CAFTA & access to meds: transcript from journalist teleconference   Sharonann Lynch
• [Ip-health] FTC & Collateral Damages of Monopoly   ds20@uow.edu.au
• [Ip-health] IFPMA release on neglected diseases   Mike Palmedo
• [Ip-health] Six-page IFPMA brochure on neglected diseases   Mike Palmedo
• [Ip-health] Canada fires back at Hastert for drug-pricing remarks   James Love
• [Ip-health] IP: Question Assumptions   George M. Carter
• [Ip-health] FDA extends Bayer's CIPRO monopoly 6 months   James Love
• [Ip-health] Moving On   stickell@Oxfam.org.uk
• [Ip-health] A bunch of business groups' statements on CAFTA   ds20@uow.edu.au
• [Ip-health] NHS hits Ranbaxy, Norton, Regent, Kent and DDSA over price fixing   James Love
• [Ip-health] Price Controls: Collaboration Partners!   George M. Carter
• [Ip-health] Letter from Rep. Allen to Robert Zoellick on US-Australia FTA...   MFJorge@aol.com
• [Ip-health] IMS Health, Magill and the ECJ   ds20@uow.edu.au
• [Ip-health] WIPO to begin preliminary examination system that will assess compliance with "main patentability criteria"   James Love
• [Ip-health] USA Today FDA on Canada drugs: No way   Kate Krauss
• [Ip-health] Novartis turns on EMR heat on rivals   Joana Ramos
• [Ip-health] Doha Redux - U.S. enters new phase of bad faith bargaining   B.Baker@arches.uga.edu
• [Ip-health] Cacutta Telegraph: Spotlight on grey area in patent law for drugs   Mike Palmedo

Last message date: Mon Dec 29 11:39:00 2003
Archived on: Sun Jan 25 10:56:32 2004

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...